Espoo, 17 June 2021 – Nordic BioTech Group Oy, marketed as NordShield® ("NordShield®" or "the Company") has received the ECO PASSPORT by OEKO-TEX® for NordShield BioLayr®, a disruptively sustainable antimicrobial treatment of textiles in the consumer area.
NordShield BioLayr®, a durable, non-biocidal, biodegradable, wood-based antiviral and industrially used antibacterial technology that is used on textiles for the consumer area, has been OEKO-TEX® certified.
ECO PASSPORT by OEKO-TEX® is an independent certification for chemicals, colorants and accessories used in the manufacturing of textiles and leather articles. The certification verifies that each individual substance in the chemical products meets the statutory requirements and that there is no harmful effect to human and environmental health of the textiles finished with the NordShield BioLayr®.
NordShield BioLayr® has earlier been also dermatologically tested with the highest grade “excellent”, and proven over 99% efficacy against MVA, a surrogate virus for enveloped viruses (e.g. SARS, MERS, Hepatitis and influenza viruses), more than 99.9% efficacy against SARS-CoV-2 (the virus causing Covid-19), as well as up to 99.9999% efficacy against bacteria.
Nordic BioTech Group, branded as NordShield®, is the world leading supplier of natural based antimicrobial solutions. NordShield® as a commercial technology was born after more than 10 years of researching, developing, testing, verifying, certifying and patenting. The result is a revolutionary technology with a unique combination of naturality, power and efficacy. This highly scalable technology enables the strongest protection with highest naturality - a creation as unique and powerful as nature and one that leaves nothing but goodness behind. Founded in 2016 and headquartered in Espoo, Finland, NordShield® is disrupting the field of antimicrobial technology through a durable, natural based and safer alternative for antimicrobial protection that can be utilised across applications and industries.
For more information, visit www.nordshield.com
Contact to NordShield®:
Emmi Kavander, Chief Communications Officer / NordShield®
This document may contain statements related to Nordic Biotech Group Oy’s future business and financial performance and future events or developments that may constitute forward-looking statements. Nordic BioTech Group Oy does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of any such statements. Nordic Biotech Group neither intends, nor assumes any obligation, to update or revise these statements in light of developments which differ from those anticipated. Nordic BioTech Group Oy and its affiliates are not liable for any decision made or action taken in conjunction with the information and/or statement in this document or for any related damage.
This document contains statements that are only applicable within the European Union and this document is intended only for distribution within the European Union. Nordic BioTech Group Oy does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of any such statements and is not liable for any such statements.